Neurgain Technologies
Biotechnology
Neurgain Technologies, Inc., was founded in 2013 by Martin Marsala, Professor of Anesthesiology, UC San Diego School of Medicine, and Michael Krupp, CEO—a proven leader with a track record in large pharma companies and leading several startups including Xfibra, Inc., to develop the technologies arising from Dr. Marsala’s. Dr. Marsala’s work has focused on the treatment of spinal cord trauma-includuced neuropathic pain and has produced numerous scientific publications and several patents.
Open Positions at Neurgain Technologies
0 positions available
No open positions at the moment
Check back later for new opportunities!